Moleculin Biotech Vs. Citius Pharmaceuticals Industry Stock Comparison

Sell

29

MBRX
Moleculin Biotech

Last Price:

2.72

Seasonality Move:

-11.13%

Sell

15

CTXR
Citius Pharmaceuticals

Last Price:

0.52

Seasonality Move:

-5.4%

Sell

29

Moleculin Biotech (MBRX) is a Sell

Is Moleculin Biotech a Buy, Sell or Hold?

The current Moleculin Biotech [MBRX] share price is $2.75. The Score for MBRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
MBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

15

Citius Pharmaceuticals (CTXR) is a Sell

Is Citius Pharmaceuticals a Buy, Sell or Hold?

The current Citius Pharmaceuticals [CTXR] share price is $0.52. The Score for CTXR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

MBRX Stock Price Chart

What is Moleculin Biotech's stock price today?

The Moleculin Biotech share price today is $2.75
The current trend is relatively stagnant and MBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CTXR Stock Price Chart

What is Citius Pharmaceuticals's stock price today?

The Citius Pharmaceuticals share price today is $0.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.

MBRX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	57.15	Buy
Chaikin Money Flow:	30415	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(2.37 - 2.57)	Buy
Bollinger Bands (100):	(2.48 - 4.44)	Sell

CTXR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.03	Sell
Relative Strength Index (14 RSI):	40.78	Sell
Chaikin Money Flow:	21586	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.51 - 0.59)	Sell
Bollinger Bands (100):	(0.54 - 0.8)	Sell

MBRX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2.53	Buy
20-day SMA:	2.47	Buy
50-day SMA:	2.63	Buy
200-day SMA:	5.6	Sell
8-day EMA:	2.54	Buy
20-day EMA:	2.51	Buy
50-day EMA:	2.77	Sell
200-day EMA:	5.11	Sell

CTXR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.53	Sell
20-day SMA:	0.53	Sell
50-day SMA:	0.67	Sell
200-day SMA:	0.71	Sell
8-day EMA:	0.53	Sell
20-day EMA:	0.55	Sell
50-day EMA:	0.61	Sell
200-day EMA:	0.72	Sell

Moleculin Biotech Earnings Growth & MBRX Earnings Dates

Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.

Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.

Moleculin Biotech Technical Analysis

	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27
	Sep
	16	17	18	19	20	23	24	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Citius Pharmaceuticals Technical Analysis

	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20	Sep 23	Sep 24	Sep 25	Sep 26	Sep 27
	Sep
	16	17	18	19	20	23	24	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):